Lower rates of bone marrow blasts and ELN favourable risk in IKZF1N159S AML likely reflect associations with chromatin/spliceosome alterations and the low NPM1 mutation frequency.13 The gene discussed is NPM1; the disease is acute myeloid leukemia.